<code id='D9BD64A12D'></code><style id='D9BD64A12D'></style>
    • <acronym id='D9BD64A12D'></acronym>
      <center id='D9BD64A12D'><center id='D9BD64A12D'><tfoot id='D9BD64A12D'></tfoot></center><abbr id='D9BD64A12D'><dir id='D9BD64A12D'><tfoot id='D9BD64A12D'></tfoot><noframes id='D9BD64A12D'>

    • <optgroup id='D9BD64A12D'><strike id='D9BD64A12D'><sup id='D9BD64A12D'></sup></strike><code id='D9BD64A12D'></code></optgroup>
        1. <b id='D9BD64A12D'><label id='D9BD64A12D'><select id='D9BD64A12D'><dt id='D9BD64A12D'><span id='D9BD64A12D'></span></dt></select></label></b><u id='D9BD64A12D'></u>
          <i id='D9BD64A12D'><strike id='D9BD64A12D'><tt id='D9BD64A12D'><pre id='D9BD64A12D'></pre></tt></strike></i>

          entertainment

          entertainment

          author:comprehensive    Page View:576
          Tome cofounders Jonathan Gootenberg, left, and Omar Abudayyeh, a scientific team that's trying to reinvent gene editing for a new era of biotech innovation.
          Suzanne Kreiter/Globe staff

          WATERTOWN — Their brainstorming began in an MIT class in 2010 when the eager undergrads shot each other emails about how to solve a bioengineering equation. It has continued for 14 years over sushi dinners, between Marvel movies, and during rowing-machine workouts.

          Together, Omar Abudayyeh, 33, and Jonathan Gootenberg, 32, have probed the mysteries of genomic editing and COVID detection. They co-published 10 scientific papers, helped launch two medical-diagnostic companies, and cofounded a Watertown startup, Tome Biosciences, that reengineers genes and cells to cure diseases. They also run the Abudayyeh-Gootenberg Lab at Harvard.

          advertisement

          Gootenberg and Abudayyeh are an unusual pair, two scientists — a Jewish American and a Palestinian American — who prefer working together in a field that often draws solitary researchers and rewards individual achievement.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          focus

          Psychedelics group wrestles with new pharma identity
          Psychedelics group wrestles with new pharma identity

          OliviaGoldhill/STATDENVER—Hecouldhavebeenarockstar,areligiousicon,thewayecstaticapplausefromthousand

          read more
          Hyundai and Kia recall nearly 92,000 vehicles and tell owners to park them outside due to fire risk
          Hyundai and Kia recall nearly 92,000 vehicles and tell owners to park them outside due to fire risk

          FILE-Alineof2022SantaFeSUV'ssitoutsideaHyundaidealershipSunday,Sept.12,2021,inLittleton,Colo.Indocum

          read more
          Moonlake's readout produced a cash windfall. Risks remain
          Moonlake's readout produced a cash windfall. Risks remain

          MollyFerguson/STATFortwodaysstartingonSunday,MoonlakeImmunotherapeuticshappilycrunchednumbersandshar

          read more

          Longer MASH drug regimen improved liver, Akero study finds

          AdobeAkeroTherapeuticssaidMondaythatextendingtreatmentwithitsexperimentaldrugfortheliverdiseaseknown